PedvaxHIB

Haemophilus influenzae type b vaccine · Merck & Co., Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PedvaxHIB, covering 2018-06-26 to 2018-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age [Phase 3]

See pricing